Skip to main content
SpringerLink
Log in

Evidence-Based Medicine

  • Chapter
Intraocular Inflammation

  • 195 Accesses

Abstract

Evidence-based medicine is the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients. The practice of evidence-based medicine means integrating individual clinical expertise with the best available external clinical evidence from systematic research. Evidence-based medicine is neither old hat nor impossible to practise and is not ‘cookbook’ medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. BenEzra D, Cohen E, Chajek T et al (1988) Evaluation of conventional therapy versus cyclosporine A in Behçet’s syndrome. Transplant Proc 20:136–143

    CAS  PubMed  Google Scholar 

  2. Dunne JA, Travers JP (1979) Topical steroids in anterior uveitis. Trans Ophthalmol Soc U K 99:481–484

    CAS  PubMed  Google Scholar 

  3. Dunne JA, Jacobs N, Morrison A et al (1985) Efficacy in anterior uveitis of two known steroids and topical tolmetin. Br J Ophthalmol 69:120–125

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Foster CS, Alter G, DeBarge RL et al (1996) Efficacy and safety of rimexolone 1 % ophthalmic suspension vs prednisolone acetate in the treatment of uveitis. Am J Ophthalmol 122:171–182

    Article  CAS  PubMed  Google Scholar 

  5. Guyatt GH, Sackett DL, Cook DJ (1993) Users’ guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 270:2598–2601

    Article  CAS  PubMed  Google Scholar 

  6. Guyatt GH, Sackett DL, Cook DJ (1994) Users’ guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 271:59–63

    Article  CAS  PubMed  Google Scholar 

  7. Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67:1656–1662

    Article  CAS  PubMed  Google Scholar 

  8. Hatemi G, Silman A, Bang D et al (2009) Management of Behcet’s disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet’s disease. Ann Rheum Dis 68:1528–1534

    Article  CAS  PubMed  Google Scholar 

  9. Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492–513

    Article  CAS  PubMed  Google Scholar 

  10. Jasper S, Vedula SS, John SS, Horo S, Sepah YJ, Nguyen QD (2013) Corticosteroids for ocular toxoplasmosis. Cochrane Database Syst Rev 4:CD007417

    PubMed Central  PubMed  Google Scholar 

  11. Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM (2013) Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology 120:371–378

    Article  PubMed  Google Scholar 

  12. Kötter I (2009) EULAR recommendations for the management of Behçet’s disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Z Rheumatol 68:157–161

    Article  PubMed  Google Scholar 

  13. Masuda K, Nakajima A, Urayama A et al (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s disease. Lancet 1:1093–1096

    Article  CAS  PubMed  Google Scholar 

  14. Murray PI (2004) Idiopathic (autoimmune) sight-threatening uveitis. In: Wormald R, Smeeth L, Henshaw K (eds) Evidence Based Ophthalmology. BMJ Books, London

    Google Scholar 

  15. Sackett DL, Rosenberg WM, Gray JA et al (1996) Evidence based medicine: what it is and what it isn’t. BMJ 312:71–72

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Saenz A, Ausejo M, Shea B et al (2000) Pharmacotherapy for Behcet’s syndrome. Cochrane Database Syst Rev (2):CD001084

    Google Scholar 

  17. Sand BB, Krogh E (1991) Topical indometacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflammatory treatment. Acta Ophthalmol 69:145–148

    Article  CAS  Google Scholar 

  18. Sfikakis PP, Markomichelakis N, Alpsoy E et al (2007) Anti-TNF therapy in the management of Behcet’s disease–review and basis for recommendations. Rheumatology (Oxford) 46:736–741

    Article  CAS  Google Scholar 

  19. Sreekantam S, Denniston AK, Murray PI (2011) Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema. Ocul Immunol Inflamm 19:353–357

    Article  PubMed  Google Scholar 

  20. The Loteprednol Etabonate US Uveitis Study Group (1999) Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol 127:537–544

    Article  Google Scholar 

  21. Yazici H, Pazarli H, Barnes CG et al (1990) A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med 322:281–285

    Article  CAS  PubMed  Google Scholar 

  22. Young BJ, Cunninghan WF, Akingbehin T (1982) Double-masked controlled clinical trial of 5 % tolmetin versus 0.5 % prednisolone versus 0.9 % saline in acute endogenous nongranulomatous anterior uveitis. Br J Ophthalmol 66:389–391

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Unit of Ophthalmology, University of Birmingham, Birmingham and Midland Eye Centre, City Hospital, Dudley Road, Birmingham, B18 7QU, UK

    Philip I. Murray PhD, FRCP, FRCS, FRCOphth

Authors
  1. Philip I. Murray PhD, FRCP, FRCS, FRCOphth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip I. Murray PhD, FRCP, FRCS, FRCOphth .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Murray, P.I. (2016). Evidence-Based Medicine. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation